NO20012116D0 - Vitamin D analoger - Google Patents

Vitamin D analoger

Info

Publication number: NO20012116D0
Authority: NO; Norway
Prior art keywords: analogues; vitamin
Prior art date: 1998-11-02

Application number

NO20012116A

Other languages

English (en)

Other versions

NO20012116L (no

NO328597B1 (no

Inventor

Jean Michel Bernardon

Original Assignee

Galderma Res & Dev

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-11-02

Filing date

2001-04-27

Publication date

2001-04-27

2001-04-27 Application filed by Galderma Res & Dev filed Critical Galderma Res & Dev

2001-04-27 Publication of NO20012116D0 publication Critical patent/NO20012116D0/no

2001-07-02 Publication of NO20012116L publication Critical patent/NO20012116L/no

2010-03-29 Publication of NO328597B1 publication Critical patent/NO328597B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
- C07C39/205—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic, containing only six-membered aromatic rings as cyclic parts with unsaturation outside the rings
- C07C39/21—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic, containing only six-membered aromatic rings as cyclic parts with unsaturation outside the rings with at least one hydroxy group on a non-condensed ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
- C07C33/26—Polyhydroxylic alcohols containing only six-membered aromatic rings as cyclic part
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
- C07C33/28—Alcohols containing only six-membered aromatic rings as cyclic part with unsaturation outside the aromatic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
- C07C39/12—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings
- C07C39/15—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings with all hydroxy groups on non-condensed rings, e.g. phenylphenol
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
- C07C43/14—Unsaturated ethers
- C07C43/178—Unsaturated ethers containing hydroxy or O-metal groups
- C07C43/1787—Unsaturated ethers containing hydroxy or O-metal groups containing six-membered aromatic rings and having unsaturation outside the aromatic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
- C07C43/23—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Dermatology (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Immunology (AREA)
Neurology (AREA)
Pulmonology (AREA)
Oncology (AREA)
Endocrinology (AREA)
Virology (AREA)
Neurosurgery (AREA)
Communicable Diseases (AREA)
Biomedical Technology (AREA)
Emergency Medicine (AREA)
Pain & Pain Management (AREA)
Toxicology (AREA)
Ophthalmology & Optometry (AREA)
Urology & Nephrology (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Cosmetics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

NO20012116A 1998-11-02 2001-04-27 Vitamin D analoger, deres anvendelse samt farmasoytisk og kosmetisk preparat inneholdende de samme NO328597B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR9813747A FR2785284B1 (fr)	1998-11-02	1998-11-02	Analogues de la vitamine d
PCT/FR1999/002637 WO2000026167A1 (fr)	1998-11-02	1999-10-28	Analogues de la vitamine d

Publications (3)

Publication Number	Publication Date
NO20012116D0 true NO20012116D0 (no)	2001-04-27
NO20012116L NO20012116L (no)	2001-07-02
NO328597B1 NO328597B1 (no)	2010-03-29

Family

ID=9532267

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20012116A NO328597B1 (no)	1998-11-02	2001-04-27	Vitamin D analoger, deres anvendelse samt farmasoytisk og kosmetisk preparat inneholdende de samme

Country Status (25)

Country	Link
US (1)	US6689922B1 (no)
EP (1)	EP1124779B1 (no)
JP (2)	JP3869658B2 (no)
KR (2)	KR100595958B1 (no)
CN (1)	CN1282636C (no)
AR (1)	AR024516A1 (no)
AT (1)	ATE288410T1 (no)
AU (1)	AU762056B2 (no)
BR (1)	BR9915247B1 (no)
CA (1)	CA2348725C (no)
DE (1)	DE69923573T2 (no)
DK (1)	DK1124779T3 (no)
ES (1)	ES2237947T3 (no)
FR (1)	FR2785284B1 (no)
HK (1)	HK1043588B (no)
HU (1)	HUP0104195A3 (no)
IL (1)	IL142759A (no)
NO (1)	NO328597B1 (no)
NZ (1)	NZ511239A (no)
PL (1)	PL197341B1 (no)
PT (1)	PT1124779E (no)
RU (1)	RU2208601C2 (no)
TW (1)	TWI242001B (no)
WO (1)	WO2000026167A1 (no)
ZA (1)	ZA200103186B (no)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6670398B2 (en)	1997-05-14	2003-12-30	Atherogenics, Inc.	Compounds and methods for treating transplant rejection
WO1998051662A2 (en)	1997-05-14	1998-11-19	Atherogenics, Inc.	Compounds and methods for the inhibition of the expression of vcam-1
US6310222B1 (en) *	1999-11-01	2001-10-30	Sumika Fine Chemicals Co., Ltd.	Production method of 5-phthalancarbonitrile compound, intermediate therefor and production method of the intermediate
FR2801307B1 (fr) *	1999-11-24	2002-12-06	Galderma Res & Dev	Analogues de la vitamine d
CN1319959C (zh) *	1999-12-06	2007-06-06	天济药业（深圳）有限公司	抗发炎、治疗牛皮癣和抑制蛋白质致活酶的羟基芪、芪衍生物及其类似物
US7321050B2 (en)	1999-12-06	2008-01-22	Welichem Biotech Inc.	Anti-inflammatory and psoriasis treatment and protein kinase inhibition by hydroxy stilbenes and novel stilbene derivatives and analogues
US6410596B1 (en) *	2000-08-16	2002-06-25	Insmed Incorporated	Compositions containing hypoglycemically active stillbenoids
US6552085B2 (en)	2000-08-16	2003-04-22	Insmed Incorporated	Compositions containing hypoglycemically active stilbenoids
PT1331927E (pt) *	2000-10-27	2008-01-30	Leo Pharma As	Composição tópica contendo pelo menos uma vitamina d ou um análogo de vitamina d e, pelo menos, um corticosteróide
KR100836207B1 (ko) *	2001-01-18	2008-06-09	웰리켐 바이오 테크 인크.	면역 질환 치료용의 신규한 1,2-디페닐에텐 유도체
FR2825087B1 (fr) *	2001-05-22	2005-01-14	Galderma Res & Dev	Analogues de la vitamine d
KR20050044655A (ko) *	2001-12-03	2005-05-12	노바세아, 인크.	활성 비타민 ｄ 화합물을 함유하는 약제학적 조성물
FR2833841B1 (fr) *	2001-12-21	2005-07-22	Galderma Res & Dev	Gel comprenant au moins un retinoide et du peroxyde de benzoyle
CA2496362C (en) *	2002-08-27	2012-03-06	Galderma Research & Development, S.N.C.	Analogues of vitamin d
FR2843962B1 (fr) *	2002-08-27	2005-12-02	Galderma Res & Dev	Analogues de la vitamine d
US20050026877A1 (en) *	2002-12-03	2005-02-03	Novacea, Inc.	Pharmaceutical compositions comprising active vitamin D compounds
WO2004101483A1 (ja) *	2003-05-14	2004-11-25	Riken	新規３置換ベンゼン誘導体、その製造方法、およびそれを含む医薬組成物
CA2528378A1 (en) *	2003-06-11	2004-12-23	Novacea, Inc.	Treatment of immune-mediated disorders with active vitamin d compounds alone or in combination with other therapeutic agents
US20060189586A1 (en) *	2003-06-11	2006-08-24	Cleland Jeffrey L	Pharmaceutical compositions comprising active vitamin D compounds
US20050020546A1 (en) *	2003-06-11	2005-01-27	Novacea, Inc.	Pharmaceutical compositions comprising active vitamin D compounds
US7318925B2 (en) *	2003-08-08	2008-01-15	Amgen Fremont, Inc.	Methods of use for antibodies against parathyroid hormone
BR0318454A (pt)	2003-08-08	2006-09-12	Abgenix Inc	anticorpos dirigidos a hormÈnio da paratireóide (pth) e seus usos
FR2862540B1 (fr) *	2003-11-21	2007-03-30	Galderma Res & Dev	Composition sous forme de spray comprenant un actif pharmaceutique, au moins un silicone volatile et une phase non polaire non volatile
PT1686972E (pt) *	2003-11-21	2008-04-23	Galderma Res & Dev	Composição pulverizável para a administração de derivados da itamina d
FR2867682B1 (fr) *	2004-03-22	2009-06-05	Galderma Res & Dev	Composition pharmaceutique anhydre associant un agent silicone et un principe actif solubilise.
EP1748784A4 (en) *	2004-05-26	2008-02-13	Cedars Sinai Medical Center	INDUCTION OF IMMUNITY IN VITAMIN D3 AND ITS ANALOGUES
US8158136B2 (en)	2004-08-18	2012-04-17	L'oréal	Emulsification system for use in cosmetics
FR2878245B1 (fr) *	2004-11-19	2007-02-16	Galderma Res & Dev	Nouveau procede de preparation du 3-(5'-(3,4-bis hydroxymethyl-benzyloxy)-2'-ethyl-2-propyl-biphenyl-4-yl)- penta-3ol
FR2892936A1 (fr)	2005-11-10	2007-05-11	Galderma Res & Dev	Composition pharmaceutique ou cosmetique, et procede de solubilisation mixte pour preparer la composition.
US8252840B2 (en)	2007-03-26	2012-08-28	Salutria Pharmaceuticals Llc	Methods of derivatives of probucol for the treatment of type II diabetes
FR2928542B1 (fr)	2008-03-13	2011-12-09	Oreal	Procede de maquillage des levres
KR20170096238A (ko) *	2009-01-27	2017-08-23	베르그 엘엘씨	화학요법과 연관된 부작용을 경감시키기 위한 비타민 ｄ３ 및 이의 유사물
US8470304B2 (en) *	2009-08-04	2013-06-25	Avidas Pharmaceuticals Llc	Therapeutic vitamin D sun-protecting formulations and methods for their use
MX338746B (es)	2009-08-14	2016-04-29	Berg Llc	Vitamina d3 y analogos de la misma para tratar alopecia.
WO2011063241A1 (en)	2009-11-20	2011-05-26	Rigel Pharmaceuticals, Inc.	2,4-pyrimidinediamine compounds and prodrugs thereof and their uses
FR2953716B1 (fr)	2009-12-16	2015-03-27	Oreal	Kit de formulation d'un produit cosmetique
WO2011130390A1 (en)	2010-04-13	2011-10-20	Rigel Pharmaceuticals, Inc.	2, 4-pyrimidinediamine compounds and prodrugs thereof and their uses
US9949897B2 (en)	2012-04-11	2018-04-24	L'oreal	Self-standing cosmetic sheet
DE102012014042A1 (de)	2012-07-14	2014-01-16	Friedrich Haas	Nahrungsergänzungsmittel und dessen Verwendung
BR112015002202B1 (pt)	2012-08-02	2019-10-22	Oreal	composição para a tintura das fibras queratínicas, processo para a tintura das fibras queratínicas e dispositivo
FR2994091B1 (fr)	2012-08-02	2014-08-01	Oreal	Composition de coloration comprenant de la gomme de guar non ionique ou l'un de ses derives non ionique, procede et dispositif
FR2994088B1 (fr)	2012-08-02	2019-07-05	L'oreal	Composition de coloration comprenant au moins un compose sulfonique, un polymere epaississant, procede de coloration et dispositif approprie
BR112015002215B1 (pt)	2012-08-02	2019-10-15	L'oreal	Composição para tintura das fibras queratínicas humanas, processo para tintura das fibras queratínicas humanas e dispositivo com compartimentos múltiplos
FR2994084B1 (fr)	2012-08-02	2014-10-31	Oreal	Composition de coloration sous forme de creme comprenant au moins une huile, pas ou peu d'alcool gras solide, procede de coloration et dispositif approprie
US20150148320A1 (en) *	2013-03-13	2015-05-28	Avon Products, Inc.	Cosmetic use of salicylic acid derivatives
CA2913543C (en)	2013-05-29	2024-01-09	Berg Llc	Preventing or mitigating chemotherapy induced alopecia using vitamin d
US11617724B2 (en)	2015-05-21	2023-04-04	Dermavant Sciences GmbH	Topical pharmaceutical compositions
HUE059066T2 (hu)	2015-05-21	2022-10-28	Dermavant Sciences GmbH	Topikus gyógyszerkészítmények
WO2017102793A1 (en) *	2015-12-18	2017-06-22	Dsm Ip Assets B.V.	Biaromatic vitamin d analogs
CN108366941B (zh) *	2015-12-18	2021-06-18	帝斯曼知识产权资产管理有限公司	新颖的化合物
WO2017102792A1 (en) *	2015-12-18	2017-06-22	Dsm Ip Assets B.V.	Biaromatic vitamin d analogs
CN108366938B (zh) *	2015-12-18	2021-08-24	帝斯曼知识产权资产管理有限公司	联芳香族维生素d类似物
FR3061002B1 (fr)	2016-12-23	2019-05-24	L'oreal	Composition comprenant de l’acide hydroxyethylpiperazine ethane sulfonique et au moins un alkylpolyglucoside
EP3706725A4 (en)	2017-11-10	2021-08-25	Dermavant Sciences GmbH	PROCESS FOR THE PREPARATION OF TAPINAROF
US11497718B2 (en)	2018-11-13	2022-11-15	Dermavant Sciences GmbH	Use of tapinarof for the treatment of atopic dermatitis
EP3911660B1 (en) *	2019-01-15	2023-05-10	Laurus Labs Limited	Process for preparation of 2-amino-5-hydroxy propiophenone
CN118344242A (zh) *	2024-03-07	2024-07-16	上海拜思丽实业有限公司	基于计算机辅助获得的美白小分子化合物及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4567184A (en) *	1982-12-01	1986-01-28	Usv Pharmaceutical Corporation	Certain aryl or hetero-aryl derivatives of 1-hydroxy-pentane or 1-hydroxy-hexane which are useful for treating inflammation and allergies
US4778931A (en) *	1982-12-01	1988-10-18	Usv Pharmaceutical Corporation	Certain [3-(1-hydroxy hexyl-tetrahydro)naphthalenes], the corresponding naphthalenes having anti-inflammatory and anti-allergic activity
FR2741876B1 (fr)	1995-12-01	1998-01-09	Cird Galderma	Composes biaromatiques portant un groupement adamantyl en para, compositions pharmaceutiques et cosmetiques les contenant et utilisations
FR2757852B1 (fr) *	1996-12-31	1999-02-19	Cird Galderma	Composes stilbeniques a groupement adamantyl, compositions les contenant et utilisations

1998
- 1998-11-02 FR FR9813747A patent/FR2785284B1/fr not_active Expired - Fee Related
1999
- 1999-10-16 TW TW088117922A patent/TWI242001B/zh not_active IP Right Cessation
- 1999-10-28 US US09/830,973 patent/US6689922B1/en not_active Expired - Fee Related
- 1999-10-28 WO PCT/FR1999/002637 patent/WO2000026167A1/fr not_active Ceased
- 1999-10-28 KR KR1020057008184A patent/KR100595958B1/ko not_active Expired - Fee Related
- 1999-10-28 BR BRPI9915247-9A patent/BR9915247B1/pt not_active IP Right Cessation
- 1999-10-28 KR KR10-2001-7005428A patent/KR100525022B1/ko not_active Expired - Fee Related
- 1999-10-28 CN CNB998153516A patent/CN1282636C/zh not_active Expired - Fee Related
- 1999-10-28 AU AU63476/99A patent/AU762056B2/en not_active Ceased
- 1999-10-28 DE DE69923573T patent/DE69923573T2/de not_active Expired - Lifetime
- 1999-10-28 HU HU0104195A patent/HUP0104195A3/hu unknown
- 1999-10-28 NZ NZ511239A patent/NZ511239A/en not_active IP Right Cessation
- 1999-10-28 EP EP99950869A patent/EP1124779B1/fr not_active Expired - Lifetime
- 1999-10-28 JP JP2000579557A patent/JP3869658B2/ja not_active Expired - Fee Related
- 1999-10-28 CA CA002348725A patent/CA2348725C/fr not_active Expired - Fee Related
- 1999-10-28 ES ES99950869T patent/ES2237947T3/es not_active Expired - Lifetime
- 1999-10-28 HK HK02105220.9A patent/HK1043588B/zh not_active IP Right Cessation
- 1999-10-28 DK DK99950869T patent/DK1124779T3/da active
- 1999-10-28 RU RU2001115100/04A patent/RU2208601C2/ru not_active IP Right Cessation
- 1999-10-28 PL PL347548A patent/PL197341B1/pl unknown
- 1999-10-28 IL IL142759A patent/IL142759A/en not_active IP Right Cessation
- 1999-10-28 AT AT99950869T patent/ATE288410T1/de active
- 1999-10-28 PT PT99950869T patent/PT1124779E/pt unknown
- 1999-11-01 AR ARP990105514A patent/AR024516A1/es active IP Right Grant
2001
- 2001-04-19 ZA ZA200103186A patent/ZA200103186B/en unknown
- 2001-04-27 NO NO20012116A patent/NO328597B1/no not_active IP Right Cessation
2005
- 2005-07-15 JP JP2005207861A patent/JP2006028185A/ja active Pending

Also Published As

Publication number	Publication date
HK1043588B (zh)	2007-06-15
HUP0104195A2 (hu)	2002-03-28
CA2348725C (fr)	2007-04-17
PT1124779E (pt)	2005-06-30
AU6347699A (en)	2000-05-22
KR100595958B1 (ko)	2006-07-03
HUP0104195A3 (en)	2002-04-29
CA2348725A1 (fr)	2000-05-11
KR20050047142A (ko)	2005-05-19
EP1124779A1 (fr)	2001-08-22
KR20010081102A (ko)	2001-08-27
ATE288410T1 (de)	2005-02-15
EP1124779B1 (fr)	2005-02-02
PL347548A1 (en)	2002-04-08
NO20012116L (no)	2001-07-02
KR100525022B1 (ko)	2005-10-31
AU762056B2 (en)	2003-06-19
JP3869658B2 (ja)	2007-01-17
DE69923573T2 (de)	2006-01-05
US6689922B1 (en)	2004-02-10
CN1332711A (zh)	2002-01-23
AR024516A1 (es)	2002-10-16
DE69923573D1 (de)	2005-03-10
HK1043588A1 (en)	2002-09-20
WO2000026167A1 (fr)	2000-05-11
PL197341B1 (pl)	2008-03-31
DK1124779T3 (da)	2005-06-06
BR9915247B1 (pt)	2012-05-29
BR9915247A (pt)	2001-10-30
ZA200103186B (en)	2001-11-22
FR2785284A1 (fr)	2000-05-05
NZ511239A (en)	2003-11-28
NO328597B1 (no)	2010-03-29
JP2006028185A (ja)	2006-02-02
TWI242001B (en)	2005-10-21
RU2208601C2 (ru)	2003-07-20
IL142759A (en)	2008-06-05
JP2002528523A (ja)	2002-09-03
IL142759A0 (en)	2002-03-10
ES2237947T3 (es)	2005-08-01
CN1282636C (zh)	2006-11-01
FR2785284B1 (fr)	2000-12-01

Publication	Publication Date	Title
DK1124779T3 (da)	2005-06-06	D-vitaminanaloge forbindelser
DK1070058T3 (da)	2003-08-18	(4-Arylsulfonylamino)-tetrahydropyran-4-carboxylsyrehydroxamider
ATE341990T1 (de)	2006-11-15	Sigmidoskop
DE59902874D1 (de)	2002-10-31	Buchsenkontakt
DK1235777T3 (da)	2004-09-20	Vitamin D-analoger
DK0808833T3 (da)	2005-01-31	D3-vitamin-analoger
DE59907306D1 (de)	2003-11-13	Fadenchangierung
DE59905487D1 (de)	2003-06-12	Handlauf
NO996252L (no)	2000-06-19	Ettborings-stigerør
DK1200399T3 (da)	2004-07-19	Vitamin D3-analoger
DK1235824T3 (da)	2004-06-28	D-vitaminanaloge forbindelser
DE59903966D1 (de)	2003-02-13	Exzenterzahnradgetriebe
ATE262513T1 (de)	2004-04-15	Benzoylpyridazine
DE59908769D1 (de)	2004-04-08	N-arylsulfonyl-aminosäure-omega-amide
DE59903106D1 (de)	2002-11-21	Tripode-gleichlaufdrehgelenk
DE59908057D1 (de)	2004-01-29	Underdruckhandhabungseinrichung
ATA20199A (de)	2000-02-15	Fluggerät
DE59808995D1 (de)	2003-08-14	Endomikroskopsystem
FI980759A0 (fi)	1998-04-02	Taetningskonstruktion foer suglaodan i en sugvals
DE19842103B4 (de)	2005-03-10	Stanznietzuführung
DE59900612D1 (de)	2002-02-21	Dispersionsazofarbstoffmischungen
DE59903616D1 (de)	2003-01-16	Rollenwicklerwalze
PT1076660E (pt)	2002-11-29	(4-bromopirazol-3-il)-benzazolos substituidos
DE59901263D1 (de)	2002-05-23	Einzelplatz-sortierer
DE59910289D1 (de)	2004-09-23	Friktionsdrallvorrichtung

Legal Events

Date	Code	Title	Description
2016-05-23	MM1K	Lapsed by not paying the annual fees